Key facts
- It has raised $200K; the latest was Out of Business in Jan 2026.
- Status: Out of Business.
- ·Watchlist + deal alerts for MiFi
- ·The full record, as it builds
Funding rounds
No funding rounds for MiFi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MiFi
Developer of a diagnostic software platform designed for rapid pathogen detection in next-generation sequencing data. The company's tool utilizes proprietary pathogen-specific probes and algorithms to analyze host tissue samples uploaded by users, enabling researchers and professionals to accurately identify the presence of various pathogens in a given sample, providing results with a confidence interval within hours.
- Sector
- Healthcare
- HQ
- Stillwater, OK, United States
- Founded
- 2019
- Website
- app.mifi.tech/
- Ownership
- Out of Business
MiFi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MiFi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MiFi in its N-PORT filings yet. We sweep new filings monthly.